Reflect Scientific, Inc.: Form 10-Q for the period ended Jun 30, 2021
Filed with the SEC on Aug 16, 2021 and accepted by EDGAR at Aug 16, 2021, 17:27 ET.
Sections
EDGAR did not return this filing’s main document when we asked, so its sections were not extracted. Read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-04-01 to 2021-06-30 | $707.1k | us-gaap:Revenues |
| Revenue | 6 months2021-01-01 to 2021-06-30 | $1.3m | us-gaap:Revenues |
| Cost of revenue | 3 months2021-04-01 to 2021-06-30 | $235.2k | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2021-01-01 to 2021-06-30 | $379.0k | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2021-04-01 to 2021-06-30 | $472.0k | us-gaap:GrossProfit |
| Gross profit | 6 months2021-01-01 to 2021-06-30 | $890.5k | us-gaap:GrossProfit |
| Research and development | 3 months2021-04-01 to 2021-06-30 | $19.5k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2021-01-01 to 2021-06-30 | $28.2k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2021-04-01 to 2021-06-30 | $170.8k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2021-01-01 to 2021-06-30 | $307.3k | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2021-04-01 to 2021-06-30 | $170.8k | us-gaap:NetIncomeLoss |
| Net income | 6 months2021-01-01 to 2021-06-30 | $418.5k | us-gaap:NetIncomeLoss |
| Operating cash flow | 6 months2021-01-01 to 2021-06-30 | $415.2k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2021-06-30 | $1.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-06-30 | $1.8m | us-gaap:AssetsCurrent |
| Total assets | At period end2021-06-30 | $2.0m | us-gaap:Assets |
| Current liabilities | At period end2021-06-30 | $325.1k | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-06-30 | $406.7k | us-gaap:Liabilities |
| Shareholders' equity | At period end2021-06-30 | $1.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001548123-21-000100. Last ingested by Listed: Oct 24, 2026, 15:01 ET. Listed shows no prices and gives no investment advice.